image
Viking Therapeutics, Inc. VKTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 27.53
-8.41 %
$ 3.09 B
Market Cap
-23.28
P/E
BALANCE SHEET
908 M ASSETS
146.50%
Growth Rates
1Year 146.50%
3Years 62.76%
5Years 26.16%
7Years 70.02%
10Years 76.80%
28 M LIABILITIES
39.72%
Growth Rates
1Year 39.72%
3Years 47.28%
5Years 31.48%
7Years 18.28%
10Years 1.09%
880 M EQUITY
152.65%
Growth Rates
1Year 152.65%
3Years 63.37%
5Years 26.01%
7Years 81.70%
10Years 45.24%
BALANCE SHEET DECOMPOSITION
Balance Sheet Viking Therapeutics, Inc.
image
Current Assets 907 M
Cash & Short-Term Investments 903 M
Receivables 0
Other Current Assets 4.6 M
Non-Current Assets 1.1 M
Long-Term Investments 0
PP&E 1 M
Other Non-Current Assets 102 K
99.37 %Total Assets$908.3m
Current Liabilities 27.4 M
Accounts Payable 9.81 M
Short-Term Debt 489 K
Other Current Liabilities 17.1 M
Non-Current Liabilities 630 K
Long-Term Debt 0
Other Non-Current Liabilities 630 K
34.99 %61.02 %Total Liabilities$28.0m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 26.7 55.5 36.6 26.4 29.1 8.4 24.8 9.0 3.1 0.8 0.8 0.2 0
Short Term Investments 875.9 306.6 118.9 175.7 219.3 267.3 276.7 11.6 10.1 13.3 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 4.6 5.1 11.6 8.4 7.7 0.4 0.3 1.3 1.6 2.2 17.8 K 0 0
Total Current Assets 907.2 367.2 167.0 210.5 256.1 283.5 302.1 21.9 14.0 15.2 0.8 0.2 0
PP&E 1.0 1.1 1.4 25 K 0.3 0.6 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.1 0.1 71 K 0.1 77 K 0.2 0.2 0.3 0.6 0.2 2.3 775 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 908.3 368.5 168.5 210.7 256.5 284.3 302.3 22.1 14.5 15.4 3.0 0.2 0
LIABILITIES
Accounts Payable 9.8 7.5 8.5 1.4 4.0 2.4 1.0 1.5 1.2 0.6 1.8 74.1 K 54 K
Short Term Debt 0.5 0.3 0.6 58 K 0.7 0.6 0 3.5 3.3 0 0.3 46.9 K 0
Other Current Liabilities 17.1 11.3 12.8 7.3 7.5 3.7 3.6 3.7 2.0 1.4 20.4 6.51 K 350
Total Current Liabilities 27.4 19.1 21.9 8.8 12.1 6.8 4.5 8.7 6.5 2.0 22.5 0.1 54.4 K
Long Term Debt 0 0.9 1.3 0 29 K 0.4 0 0 0 2.2 1.3 0.2 42.8 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 12 K 0 16.3 K 2.6 1.4 71.7 K 8.29 K
Total Liabilities 28.0 20.1 23.2 8.8 12.2 7.1 4.6 8.7 6.5 6.7 25.2 0.4 0.1
EQUITY
Common Stock 1 K 1 K 1 K 1 K 1 K 1 K 1 K 358 208 97 60 52 50
Retained Earnings (487.9) (377.9) (292.0) (223.2) (168.2) (128.7) (102.9) (80.9) (60.3) (45.5) (22.1) (0.3) (0.1)
Other Accumulative Comprehensive Income/Loss (0.8) (0.4) (1.1) (0.5) 54 K 12 K (0.4) 19.8 K 6.89 K 7.37 K 0 4.5 K 0
Total Equity 880.3 348.4 145.3 201.9 244.3 277.1 297.8 13.5 8.0 8.7 (22.1) (0.3) (0.1)
Total Liabilities and Equity 908.3 368.5 168.5 210.7 256.5 284.3 302.3 22.1 14.5 15.4 3.0 0.2 0
SHARES OUTSTANDING
Common Shares Outstanding 109.0 94.3 76.8 77.2 72.6 72.0 57.6 26.0 16.3 6.4 4.3 4.3 1.48 K